Article info
PDFEditorial commentary
At the dawn of personalised medicine in neuromyelitis optica spectrum disorder: the impact of the disease activity on pregnancy
- Correspondence to Dr Norio Chihara, Neurology, Kobe Univerisity, Kobe, Japan; chiharan{at}med.kobe-u.ac.jp
Citation
At the dawn of personalised medicine in neuromyelitis optica spectrum disorder: the impact of the disease activity on pregnancy
Publication history
- Received August 20, 2020
- Accepted August 20, 2020
- First published November 20, 2020.
Online issue publication
December 15, 2020
Article Versions
- Previous version (20 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.